Submission + - Canada's Ebola Vaccine Nets Millions for Tiny US Biotech Firm (thestar.com) 1
Anita Hunt (lissnup) writes: Iowa-based NewLink Genetics has secured a US$50million deal with pharmaceutical giant Merck for the experimental Ebola vaccine developed by Canadian government scientists. NewLink bought the exclusive commercial licensing rights to Canada’s VSV-EBOV in 2010 with a milestone payment of just US$205,000. This is an interesting new twist in a story previously discussed on /. and which continues to draw media attention.